[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Medical Devices – the picture is still clear as mud!

Medical Devices – the picture is still clear as mud!

by John Finey | Aug 30, 2023 | Blog, Medical Devices

Let’s throw in some more cliches, there are still many plates spinning, balls in the air and how long is a piece of string?

NIMAR – The list was updated 21.12.2022

NIMAR – The list was updated 21.12.2022

by Ryan Watts | Dec 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

NIMAR – The list was updated 21.12.2022

NIMAR – The list is getting longer…

by Sally Finlayson | Nov 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

The value of proper Export training – be prepared!

The value of proper Export training – be prepared!

by Steven Hewison | Nov 4, 2022 | Blog, Export, Training

Many clients contact us for information and help on expanding the scope of their WDA license to include the ability to export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.

The need for more Superintendent Pharmacist training and support

The need for more Superintendent Pharmacist training and support

by Sehar Shahid | Nov 2, 2022 | Blog, Training

Many pharmacists don’t feel confident or have a full understanding of the role and responsibilities of a superintendent pharmacists.

MHRA Response to contaminated paediatric medicines

MHRA Response to contaminated paediatric medicines

by Amelia Holmes | Oct 27, 2022 | Blog, GDP/RP, Good Distribution Practice - GDP, MHRA, Training

On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.

« Older Entries
Next Entries »

Recent Posts

  • Medical Devices: Conformity Assessment and the UKCA Mark
  • Are Audit clip boards and checklists obsolete?
  • Major Changes to MHRA Medical Device Registration Fees

Upcoming Courses

  • GDP Audit Online Training on 9 March 2026 10:00 am
  • Export Online Training on 12 March 2026 10:00 am
  • Understanding GPhC Guidance for Online Pharmacies – Online Training on 16 March 2026
  • GDP/RP Cogent Gold Standard Online Training on 17 March 2026
  • GDP/RP Cogent Gold Standard WEEKEND Training on 20 March 2026 9:30 am

MHRA Alerts & Recalls

Field Safety Notices: 23-27 February 2026
3 March 2026
MHRA Safety Roundup: February 2026
25 February 2026
Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution, EL(26)A/10
24 February 2026
Field Safety Notices: 16-20 February 2026
24 February 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow